Mutations in a gene that helps regulate copper and oxygen levels in eye tissue are associated with a severe form of nearsightedness, according to a study published in the American Journal of Human Genetics on May 2, 2013.
Nearsightedness – also known as myopia – is the most common human eye disease in the world. It occurs if the eye is too long or the cornea has too much curvature, which keeps light entering the eye from focusing correctly.
High-grade myopia, a more severe form of nearsightedness, affects up to two percent of Americans and is especially common in Asian populations. Individuals with high-grade myopia are at an increased risk for other serious eye problems, including retinal detachment, cataracts and glaucoma.
Studies suggest that myopia is caused by a combination of environmental factors, such as large amounts of reading, and genetics. Nearsightedness runs in families, but little is understood about genetic factors that cause it.
In recent years, researchers have reported several genes or locations of genes associated with myopia, and have continued to search for additional clues.
“This is the first time a gene mutation for autosomal dominant nonsyndromic high-grade myopia in Caucasians has been discovered,” said senior author Terri Young, M.D., MBA, professor of ophthalmology, pediatrics and medicine at the Duke Eye Center, Duke Center for Human Genetics and the Duke-National University of Singapore Graduate Medical School (Duke-NUS). “Our findings reflect the hard work and collaboration of our international research team.”
In this study, Young and her colleagues sought to identify these genetic factors by studying families with high-grade myopia. They performed next-generation deep sequencing on four relatives from an 11-member American family of European descent.
Analyzing DNA extracted from blood and saliva, the researchers identified mutations in the SCO2 gene in common among family members with high-grade myopia, but absent in those family members with no myopia. They confirmed four mutations in the SCO2 gene in an additional 140 people with high-grade myopia.
Once the researchers identified the mutations in DNA samples, they turned to human eye tissue and verified that the SCO2 gene was expressed in areas of the eye connected to nearsightedness.
To further support their findings, they performed an experiment in which mice were made nearsighted in one eye by wearing a strong lens. Collaborators at Duke-NUS, the Singapore Eye Research Institute and Yong Loo Lin School of Medicine at the National University of Singapore found that SCO2 gene expression decreased in the nearsighted eye, suggesting that SCO2 may play a role in the development of nearsightedness.
In the body, the SCO2 gene helps metabolize copper, an element important for regulating oxygen levels in eye tissue. Increased stress brought on by too much oxygen may alter the eye’s development and function.
Dennis J. Thiele, PhD, George Barth Geller Professor in the Department of Pharmacology and Cancer Biology at Duke, said the finding suggests that different kinds of mutations in the SCO2 gene result in different diseases. Thiele, an expert in copper metabolism who was not involved in the research, noted that another SCO2 gene mutation is responsible for a lethal form of cardiomyopathy.
“This is a fascinating finding, and it points to the relevance of copper metabolism to a spectrum of different human diseases,” Thiele said.
Since normal copper metabolism is important for eye health, future research may focus on whether copper deficiency could place someone at higher risk for nearsightedness.
“Our findings, plus information from the literature, suggest that copper deficiency could predispose people to develop myopia,” Young said. “While this wasn’t directly tested in this study, it’s possible that our diets – which are deficient in a number of minerals and vitamins – play a role, and it may be something as easy as taking a supplement with copper that helps thwart the development of myopia.”
Young noted that multiple factors are likely responsible for developing nearsightedness, and this warrants additional research. She hopes to continue by studying animal models with SCO2 mutations to better understand the gene’s connection with nearsightedness.
In addition to Young, coauthors include Khanh-Nhat Tran-Viet, Caldwell Powell and Erica Nading of Duke; Yi-Ju Li of Duke, Duke-NUS and Yong Loo Lin School of Medicine at the National University of Singapore (NUS); Steve Rozen and Thomas Klemm of Duke-NUS; Veluchamy A. Barathi of Duke-NUS, Singapore Eye Research Institute and Yong Loo Lin School of Medicine at NUS; Candace Ho of the Singapore Eye Research Institute; Sebastian Maurer-Stroh of the Agency for Science Technology and Research and Nanyang Technological University in Singapore; Vincent Soler of the Université Paul Sabatier in France; Tammy Yanovitch of the University of Oklahoma/Dean McGee Eye Institute; Georg Schneider of the Agency for Science Technology and Research in Singapore and Institute of Science and Technology Austria; Ravikanth Metlapally of the University of California, Berkeley; Seang-Mei Saw of the Yong Loo Lin School of Medicine at NUS; and Liang Goh of Duke-NUS and the Yong Loo Lin School of Medicine at NUS.
The research was supported by the National Institutes of Health (R01 EY014685), the Lew Wasserman Award from Research to Prevent Blindness Inc., a Duke-NUS core grant, the Toulouse Hospital Young Researcher Fellowship, the Fondation pour la Recherche Médicale, Fondation de France and the National Medical Research Council of Singapore.